Molecular Structure (3f3b363b Fe6d 4dee 89bd C2ca992dcf49 01)
Glycopyrrolate Injection
Product Images NDC 71872-7093
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 mL Vial Label (3f3b363b Fe6d 4dee 89bd C2ca992dcf49 02)
This is a product label for Glycopyrrolate injection, USP, at a concentration of 0.2mg/mL. It is not recommended for use in newborns less than 1% and contains benzyl alcohol. The medication can be given either intramuscularly or intravenously. The manufacturer is Wotsc Liies and manufactured for Somerset Therapeutics. Specific dosage information is provided in the single-dose vial package insert.*
Pdp (7093)
This is a description of Glycopyrrolate Injection, which is a prescription medicine used for Intramuscular or Intravenous Administration. The product contains Benzyl Alcohol and is not for use in newborns. The usual dosage is indicated in the package insert. The medicine should be stored between 20°C to 25°C and is manufactured by Wintac Limited, manufactured for Somerset Therapeutios, LLC. The manufacturer NOC is 700880011-25. Medical Purchasing Solutions based in Scottsdale, AZ 85260 is the distributor of this product.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
